Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
A total of eighty six blood samples (17, 19 & 50 of nasopharyngeal carcinoma, oesophageal cancer and normal healthy control respectively) were collected from Naga Hospital, Kohima, Nagaland and B. Barooah Cancer Institute, Guwahati, Assam and were processed for the detection of EBV-IgG antibody using Elisa test. The results showed that EBV positivity is higher among NPC patients as compared to oesophageal carcinoma patients and/or healthy control. The data also indicated that EBV antibody titre is significantly higher among NPC cases as compared to control.